Hypoxia-imaging with 18F-Misonidazole and PET: Changes of kinetics during radiotherapy of head-and-neck cancer

Radiotherapy and Oncology

Volumn 83, Issue 3, 2007, Pages 406-410

  Eschmann, Susanne Martina ^a   Paulsen, Frank ^b   Bedeshem, Claudia ^b   Machulla, Hans Jürgen ^c   Hehr, Thomas ^b   Bamberg, Michael ^b   Bares, Roland ^b  

^a MARIENHOSPITAL STUTTGART   (Germany)

^b Department of Radiooncology ^*

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

18F Misonidazole PET; Head and neck cancer; Kinetics; Radiotherapy

Indexed keywords

1 FLUORO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL F 18;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG UPTAKE; FEMALE; HEAD AND NECK CANCER; HUMAN; HYPOXIA; IMAGING; KINETICS; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIATION DOSE;

AGED; CARCINOMA, SQUAMOUS CELL; CELL HYPOXIA; FEMALE; FLUORINE RADIOISOTOPES; HEAD AND NECK NEOPLASMS; HUMANS; KINETICS; MALE; MIDDLE AGED; MISONIDAZOLE; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; RADIATION-SENSITIZING AGENTS;

EID: 34250334707     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2007.05.014     Document Type: Article

References (12)

1. Brizel D.M., Scully S.P., Harrelson J.M., et al. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res 56 (1996) 941-943
2. Brizel D.M., Sibley G.S., Prosnitz L.R., Scher R.L., and Dewhirst M.W. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 38 (1997) 285-289
3. 2 predicts survival in advanced cancer of the uterine cervix. Radiother Oncol 26 (1993) 45-50
4. Olive P.L., Vikse C.M., and Durand R.E. Hypoxic fractions measured in murine tumors and normal tissues using the comet assay. Int J Radiat Oncol Biol Phys 29 (1994) 487-491
5. Olive P.L., Durand R.E., Le Riche J., Olivotto I.A., and Jackson S.M. Gel electrophoresis of individual cells to quantify hypoxic fraction in human breast cancers. Cancer Res 53 (1993) 733-746
6. Evans S.M., Jenkins W.T., Joiner B., Lord E.M., and Koch C.J. 2-Nitroimidazole (EF5) binding predicts radiation resistance in individual 9L s.c. tumors. Cancer Res 56 (1996) 405-411
7. Koh W.J., Rasey J.S., Evans M.L., et al. Imaging of tumor hypoxia in human tumors with [F-18]fluoromisonidazole. Int J Radiat Oncol Biol Phys (1991) 199-212
8. Koh W.J., Bergman K.S., Rasey J.S., et al. Evaluation of oxygenation status during fractionated radiotherapy in human non small cell lung cancers using [F-18]fluoromisonidazole positron emission tomography. Int J Radiat Oncol Biol Phys 33 (1995) 391-398
9. Rasey J.S., Koh W.J., Evans M.L., et al. Quantifying regional hypoxia in human tumors with positron emission tomography of [F-18]fluoromisonidazole: a pretherapy study of 37 patients. Int J Radiat Oncol Biol Phys 36 (1996) 417-428
10. 18F]FDG PET imaging in soft tissue sarcomas: correlation of hypoxia, metabolism and VEGF expression. Eur J Nucl Med 30 (2003) 695-704
11. Eschmann S.M., Paulsen F., Reimold M., et al. Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy. J Nucl Med 46 (2005) 253-260
12. 18F]Fluoromisonidazole by nucleophilic substitution on THP-protected precursor: yield dependence on reaction parameters. J Radioanal Nucl Chem 240 (1999) 925-927